NL-OMON49429招募中2 期
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long-Duration Type 1 Diabetes Mellitus - FMT-Restore-DM1-trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Patients with >5 years type 1 diabetes
- •-Aged 18-65 years
- •-BMI 18-30 kg/m2
- •-Male/females
- •-No concomitant medication except insulin
排除标准
- •-Inability to provide written informed consent
- •-Evidence for absent residual beta cel function (undetectable C-peptide)
- •-Antibiotics use in the last 3 months and proton-pump inhibitor use
- •-Evidence for compromised immunity
- •-Second auto-immune disease (i.e. coeliac disease, hyper- or hypothyroidism,
- •inflammatory bowel disease)
研究者
相似试验
招募中
不适用
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long- Duration Type 1 Diabetes Mellitustype 1 diabetesNL-OMON27205Amsterdam UMC34
招募中
2 期
*Fecal Microbiota Transplantation to Preserve Residual Beta Cell Function In Patients With Newly-Diagnosed Type 1 Diabetes Mellitus: The FMT-Preserve-DM1-trial*Type 1 diabetesjuveline diabetes10018424NL-OMON54931Academisch Medisch Centrum34
撤回
2 期
Fecal Microbiota Transplantation for eradication of Vancomycin-resistant Enterococci (FAVOR): a pilot studyCarriage of vancomycin-resistant Enterococvancomycin-resistant Enterococ carrier10004018NL-OMON46675niversitair Medisch Centrum Utrecht10
进行中（未招募）
Unknown
Role of transplantation of fecal microbiota from healthy individuals to patients with Crohn's disease and its effect on achieving control of disease activityCrohn's disease of both small and large intestineDigestive SystemISRCTN15318304Dayanand Medical College & Hospital36
尚未招募
不适用
Fecal microbiota transplantation for eradication of Vancomycin-Resistant EnterococciVancomycin-resistant Enterococci carriageAntibiotic resistanceDragerschap vancomycine-resistente Enterococ Antibiotica resistentieNL-OMON25381niversity Medical Center Utrecht10